TG - Tredegar Corporation
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZAÂ (olezarsen) a
NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / Trifecta Gold Ltd. (TSXV:TG)(OTCQB:TRRFF) ("Trifecta" or the "Company") announces that further to its news release dated June 15, 2026, the Company has increased its previously announced Private Placement of Flow-through shares to consist of the sale of up to 5,750,000 Flow-through shares at a price of $0.20 per Flow-through share.
Grafton Group LON: GFTU outlined a five-year growth plan at its Capital Markets Event, with management emphasizing the company's European distribution platform, cash generation and acquisition strategy as key drivers of shareholder value through 2030.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Bonnell Leadership Changes.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Director Transitions.
RICHMOND, Va.--(BUSINESS WIRE)--SUSAN SWEENEY JOINS TREDEGAR AS VICE PRESIDENT AND CHIEF HUMAN RESOURCES OFFICER.
[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today presented new positive clinical data for plozasiran supporting its use in patients with moder
Tredegar posts a sharp year-over-year increase in Q1 earnings per share as pricing gains and stronger aluminum extrusion margins offset softer demand and weakness in High Performance Films.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS FIRST QUARTER 2026 RESULTS.
TG reports a year-over-year increase in Q4 earnings per share and revenues, driven by Aluminum Extrusions, though weakness in High Performance Films and tariff pressures weigh on overall performance.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Plans to Release Fourth Quarter 2025 Financial Results on March 11, 2026.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR APPOINTS DAVID PARKS TO BOARD OF DIRECTORS.
Tredegar Corporation (NYSE: TG - Get Free Report) major shareholder William Gottwald sold 24,823 shares of the stock in a transaction that occurred on Friday, January 23rd. The shares were sold at an average price of $8.52, for a total value of $211,491.96. Following the completion of the sale, the insider directly owned 640,992 shares of
Tredegar Corporation (NYSE: TG - Get Free Report) major shareholder John Gottwald sold 24,824 shares of the business's stock in a transaction on Friday, January 23rd. The shares were sold at an average price of $8.52, for a total transaction of $211,500.48. Following the transaction, the insider owned 640,992 shares of the company's stock, valued at